CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024

Agenda Topics: Right Disease, Right Drug, Right Patient, Right Trial Overview of the DLB disease state, unmet need and current treatment landscape for patients Understanding the role of the basal forebrain cholinergic system in clinical disease expression and progression in patients with DLB Neflamapimod mechanism of action and therapeutic potential to reverse disease progression in the basal forebrain cholinergic system Understanding the role of plasma phosphorylated tau in the selection of patients for in ...